Sign in

CIK 0001829635 · <br>Emerging growth company

Transcode Therapeutics, Inc.

Sign in to watch
Ticker
RNAZ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811065054
Phone
857-301-6857
Business address
6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
  1. S-3 Offering Registration Statement
  2. 10-K/A Report 10-K/A
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 10-K Report Annual Report
  5. DEFA14A Proxy Proxy Materials
  6. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
  7. NT 10-K Other NT 10-K
  8. DEFA14A Proxy Proxy Materials
  9. 8-K Event Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure · Other events
  10. 8-K Event Regulation FD disclosure
  11. 8-K Event Regulation FD disclosure
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 8-K Event Regulation FD disclosure
  14. DEFA14A Proxy Proxy Materials
  15. 8-K/A Event Other events
  16. EFFECT Other Notice of Effectiveness
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Executive or director change · Regulation FD disclosure
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 3 of 17 · 324 filings